Literature DB >> 24343819

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.

Ekua Weba Brenu1, Teilah K Huth, Sharni L Hardcastle, Kirsty Fuller, Manprit Kaur, Samantha Johnston, Sandra B Ramos, Don R Staines, Sonya M Marshall-Gradisnik.   

Abstract

Perturbations in immune processes are a hallmark of a number of autoimmune and inflammatory disorders. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is an inflammatory disorder with possible autoimmune correlates, characterized by reduced NK cell activity, elevations in regulatory T cells (Tregs) and dysregulation in cytokine levels. The purpose of this article is to examine innate and adaptive immune cell phenotypes and functional characteristics that have not been previously examined in CFS/ME patients. Thirty patients with CFS/ME and 25 non-fatigued controls were recruited for this study. Whole blood samples were collected from all participants for the assessment of cell phenotypes, functional properties, receptors, adhesion molecules, antigens and intracellular proteins using flow cytometric protocols. The cells investigated included NK cells, dendritic cells, neutrophils, B cells, T cells, γδT cells and Tregs. Significant changes were observed in B-cell subsets, Tregs, CD4(+)CD73(+)CD39(+) T cells, cytotoxic activity, granzyme B, neutrophil antigens, TNF-α and IFN-γ in the CFS/ME patients in comparison with the non-fatigued controls. Alterations in B cells, Tregs, NK cells and neutrophils suggest significant impairments in immune regulation in CFS/ME and these may have similarities to a number of autoimmune disorders.

Entities:  

Keywords:  B cells; NK cells; degranulation; dendritic cells; γδT cells

Mesh:

Substances:

Year:  2013        PMID: 24343819     DOI: 10.1093/intimm/dxt068

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  36 in total

1.  Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Santiago Herrera; Wilfred C de Vega; David Ashbrook; Suzanne D Vernon; Patrick O McGowan
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

2.  Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Authors:  F Mensah; A Bansal; S Berkovitz; A Sharma; V Reddy; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

3.  Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Akiko Eguchi; Sanae Fukuda; Hirohiko Kuratsune; Junzo Nojima; Yasuhito Nakatomi; Yasuyoshi Watanabe; Ariel E Feldstein
Journal:  Brain Behav Immun       Date:  2019-11-20       Impact factor: 7.217

4.  Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Authors:  Sharni Lee Hardcastle; Ekua Weba Brenu; Samantha Johnston; Thao Nguyen; Teilah Huth; Naomi Wong; Sandra Ramos; Donald Staines; Sonya Marshall-Gradisnik
Journal:  BMC Immunol       Date:  2015-06-02       Impact factor: 3.615

5.  B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

Authors:  Øystein Fluge; Kristin Risa; Sigrid Lunde; Kine Alme; Ingrid Gurvin Rekeland; Dipak Sapkota; Einar Kleboe Kristoffersen; Kari Sørland; Ove Bruland; Olav Dahl; Olav Mella
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  D Peterson; E W Brenu; G Gottschalk; S Ramos; T Nguyen; D Staines; S Marshall-Gradisnik
Journal:  Mediators Inflamm       Date:  2015-03-05       Impact factor: 4.711

7.  Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.

Authors:  T Nguyen; D Staines; B Nilius; P Smith; S Marshall-Gradisnik
Journal:  Biol Res       Date:  2016-05-31       Impact factor: 5.612

8.  The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.

Authors:  Natalie Eaton-Fitch; Hélène Cabanas; Stanley du Preez; Donald Staines; Sonya Marshall-Gradisnik
Journal:  J Transl Med       Date:  2021-07-15       Impact factor: 5.531

9.  A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.

Authors:  Ekua W Brenu; Simon Broadley; Thao Nguyen; Samantha Johnston; Sandra Ramos; Don Staines; Sonya Marshall-Gradisnik
Journal:  J Immunol Res       Date:  2016-01-04       Impact factor: 4.818

10.  Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.

Authors:  T K Huth; E W Brenu; D R Staines; S M Marshall-Gradisnik
Journal:  Gene Regul Syst Bio       Date:  2016-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.